Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis

Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis

Background: Frontline immune checkpoint inhibitors (ICI)-based regimens in non-oncogene-addicted non-small-cell lung cancer (NSCLC) have been deeply investigated. To rank the available therapeutic options, we carried out a systematic review and Bayesian meta-analysis. Methods: A comprehensive search...

Full description

Bibliographic Details
Main Authors: Barbieri, V. (Author), Caracciolo, D. (Author), Caridà, G. (Author), Ciliberto, D. (Author), Correale, P. (Author), d'Apolito, M. (Author), Galvano, A. (Author), Pelaia, C. (Author), Riillo, C. (Author), Russo, A. (Author), Siciliano, M.A (Author), Tagliaferri, P. (Author), Tassone, P. (Author)
Format: Article
Language:English
Published: Elsevier B.V. 2022
Subjects:
checkpoints inhibitors
frontline therapy
network meta-analysis
non-small-cell lung cancer
systematic review
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items